Answers are grounded in this paper and cite their sources.
Tumor shrinkage induced by tumor immunotherapy may be preceded by inflammatory changes. This confounds the assessment of response rates to tumor immunotherapy. In this issue of Clinical Cancer Research, Wolchok et al. attempt to address this peculiarity by proposing a new set of criteria termed immune-related response criteria.
No takes yet. Share an insight, caveat, or question.
Ribas et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: